Vertex Pharmaceuticals Inc. (VRTX): Price and Financial Metrics

VRTX POWR Grades

• VRTX scores best on the Quality dimension, with a Quality rank ahead of 98.19% of US stocks.
• The strongest trend for VRTX is in Quality, which has been heading up over the past 177 days.
• VRTX ranks lowest in Momentum; there it ranks in the 15th percentile.

VRTX Stock Summary

• VRTX has a higher market value than 97.36% of US stocks; more precisely, its current market capitalization is $90,488,026,893.
• VRTX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 395.65 -- higher than 92.13% of US-listed equities with positive expected earnings growth.
• Of note is the ratio of VERTEX PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; only 8.79% of US stocks have a lower such ratio.
• If you're looking for stocks that are quantitatively similar to VERTEX PHARMACEUTICALS INC, a group of peers worth examining would be LRCX, MU, REGN, ANET, and NXPI.
• Visit VRTX's SEC page to see the company's official filings. To visit the company's web site, go to www.vrtx.com.

VRTX Valuation Summary

• VRTX's price/earnings ratio is 26.5; this is 0.19% lower than that of the median Healthcare stock.
• Over the past 243 months, VRTX's price/sales ratio has gone up 2.8.

Below are key valuation metrics over time for VRTX.

VRTX Growth Metrics

Its year over year revenue growth rate is now at 23.89%.
• Its 2 year net cashflow from operations growth rate is now at 30.02%.
• The year over year net income to common stockholders growth rate now stands at -11.26%.

Over the past 34 months, VRTX's revenue has gone up $4,111,207,000.

The table below shows VRTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	8,930.7	4,129.9	3,322
2022-09-30	8,700.561	4,046.493	3,273.21
2022-06-30	8,350.425	4,018.212	3,194.638
2022-03-31	7,947.595	2,678.645	2,451.062
2021-12-31	7,574.4	2,643.5	2,342.1
2021-09-30	7,129.659	2,140.039	2,176.18

VRTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VRTX has a Quality Grade of B, ranking ahead of 86.88% of graded US stocks.
• VRTX's asset turnover comes in at 0.564 -- ranking 66th of 681 Pharmaceutical Products stocks.
• ORGO, MDWD, and CCXI are the stocks whose asset turnover ratios are most correlated with VRTX.

The table below shows VRTX's key quality metrics over time.